LTR PHARMA LIMITED (LTP)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
LTP - LTR PHARMA LIMITED FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
Index:
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
| $0.50 13 Nov |
OPEN $0.49 |
HIGH $0.51 | 148,972 LOW $0.49 |
0.010FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
| Title | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | -3.3 |
| DPS All | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | 0.1 M |
| Book Value Per Share | xxx | xxx | xxx | 17.4 |
| Net Operating Cash Flow | xxx | xxx | xxx | -4.4 M |
| Net Profit Margin | xxx | xxx | xxx | -3,837.01 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | -32.47 % |
| Return on Invested Capital | xxx | xxx | xxx | -32.47 % |
| Return on Assets | xxx | xxx | xxx | -31.44 % |
| Return on Equity | xxx | xxx | xxx | -32.47 % |
| Return on Total Capital | xxx | xxx | xxx | -41.44 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | -4.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | 0 M |
| Long Term Debt | xxx | xxx | xxx | 0 M |
| Total Debt | xxx | xxx | xxx | 0 M |
| Goodwill - Gross | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | 32 M |
| Price To Book Value | xxx | xxx | xxx | 1.67 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capex | xxx | xxx | xxx | 0.0 M |
| Capex % of Sales | xxx | xxx | xxx | 9.03 % |
| Cost of Goods Sold | xxx | xxx | xxx | 0 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | 7 M |
| Research & Development | xxx | xxx | xxx | 3 M |
| Investments - Total | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
LTP STOCK CHART
